Restricted Stock Liabilities	6 Months Ended
Jun. 30, 2023
Restricted Stock Liabilities
Restricted Stock Liabilities	8. Restricted Stock Liabilities On December 15, 2020, the Company entered into an amendment for certain restricted stock awards and units that were previously issued to certain employees in connection with a previous merger with HubPages. Pursuant to the amendment, the Company agreed to purchase the vested restricted stock awards, at a price of $88.00 per share in 24 equal monthly installments on the second business day of each calendar month beginning on January 4, 2021, subject to certain conditions. The Company recorded the repurchase of 26,214 shares of the Company’s restricted common stock (18,150 shares during the three months ended June 30, 2022, and 26,214 shares during the six months ended June 30, 2022) on the condensed consolidated statements of stockholders’ deficiency. Effective April 4, 2022, there are no longer any shares of the Company’s common stock subject to repurchase. During the six months ended June 30, 2022, the Company paid $2,307 in cash for the repurchase ($2,152 in principal and $155 in interest). Further details are provided under the heading Repurchases of Restricted Stock in Note 18.

Restricted Stock Liabilities

6 Months Ended

Jun. 30, 2023

8. Restricted Stock Liabilities

On December 15, 2020, the Company entered into an amendment for certain restricted stock awards and units that were previously issued to certain employees in connection with a previous merger with HubPages. Pursuant to the amendment, the Company agreed to purchase the vested restricted stock awards, at a price of $88.00 per share in 24 equal monthly installments on the second business day of each calendar month beginning on January 4, 2021, subject to certain conditions.

The Company recorded the repurchase of 26,214 shares of the Company’s restricted common stock (18,150 shares during the three months ended June 30, 2022, and 26,214 shares during the six months ended June 30, 2022) on the condensed consolidated statements of stockholders’ deficiency. Effective April 4, 2022, there are no longer any shares of the Company’s common stock subject to repurchase. During the six months ended June 30, 2022, the Company paid $2,307 in cash for the repurchase ($2,152 in principal and $155 in interest).

Further details are provided under the heading Repurchases of Restricted Stock in Note 18.